Increase your sleep time by nearly two hours with this gentle exercise, finds new study
Gentle exercise including yoga, Tai Chi and jogging should be considered a primary treatment method for insomnia, a new review published in the online journal BMJ Evidence Based Medicine suggests.
Roughly one third of the population is expected to experience insomnia at some point but many treatment methods remain inaccessible — such as CBT-I — or come with potential side effects — such as medication.
This review aims to better establish exercise as an accessible treatment for insomnia while encouraging further clinical research into which forms of exercise show the most benefits, to create better guidelines for patients.
Key takeaways of the review
Exercise is a low cost and accessible treatment for insomnia
Yoga, Tai Chi and jogging effectively reduce insomnia severity
Yoga can potentially increase sleep duration by up to two hours
The systematic review undertaken by sleep scientists in China assessed 22 insomnia-focused randomized control trials featuring a total of 1,348 participants and exploring a total of 13 interventions (seven exercise-based.)
What is CBT-I?
CBT-I (Cognitive Behavioral Therapy for Insomnia) is a popular insomnia treatment that aims to reframe your approach and attitude to sleep, to improve your rest. While effective, the low number of practitioners means it's often hard to access.
Based on sleep diary data collected from these studies, yoga, Tai Chi and gentle walking or jogging were determined to have the largest positive impact on insomnia.
Yoga in particular proved effective at increasing sleep duration, adding an average of 110 minutes to the time spent snoozing — that's close to two hours.
Tai Chi also demonstrated benefits across the PSQI (Pittsburgh Sleep Quality Index, a self-reported sleep assessment), as well as improving total sleep time and the time it takes to fall asleep.
In addition, Tai Chi demonstrated long-term benefits for those who had experienced sleep difficulties, continuing to show improvement across sleep outcomes in the one to two year follow-up.
Gentle walking or jogging was also shown to reduce insomnia severity.
While the review recognizes CBT-I as the gold-standard for insomnia treatment, it encourages the above forms of exercise as "viable primary treatment options" for those experiencing insomnia. They recognize the treatments as "well-suited for integration into primary care and community health programmes."
"Body awareness, controlled breathing and attentional training"
The review theorizes that yoga and Tai Chi are particularly effective treatments for insomnia due to their focus on "body awareness, controlled breathing and attention training."
Mindfulness for sleep encourages positive, relaxed thinking, qualities that are also prominent in many forms of yoga and Tai Chi.
The study further theorizes that the "meditative movement" of Tai Chi can encourage emotional regulation while helping quiet busy thoughts. These two features might prove particularly useful for those finding anxiety or stress is keeping them awake.
As for jogging and walking, the researchers behind the review suggest a combination of energy use, increased melatonin production and improved emotion regulation make these exercises particularly sleep-inducing.
The dos and don'ts of exercising for better sleep
Establishing a consistent exercise routine can benefit your sleep and help you avoid insomnia. Here are some dos and don'ts of exercising for better sleep to get you started.
DON'T do strenuous exercise too close to bedtime
We know a packed calendar can make scheduling your workouts a workout in itself, but it's important to consider both when you're exercising and the type of activity you're engaging in to find the best time to exercise for sleep.
Vigorous exercise before bed is likely to keep you awake, as your body struggles to switch off after being put to work. However, research suggests intense workouts in the morning or afternoon can help you achieve deeper sleep.
DO add gentle exercise into your pre-bed routine
Light exercise — such as yoga, Tai Chi and walking — can be beneficial later in the day, particularly if you're using that mind-body connection to calm anxious thoughts that might otherwise plague your sleep.
A few minutes of stretching roughly an hour before bed can help reduce muscle tension and release stress, so you're more relaxed when you climb beneath the covers.
DO exercise for at least an hour a week
Consistency is equally as important as timing when it comes to exercising for better rest — an occasional stretch every few weeks is unlikely to provide any long-term sleep benefits.
Research published in the BMJ Open suggests consistent activity of at least an hour per week can lower your risk of experiencing insomnia symptoms.
DON'T neglect the rest of your sleep routine
Avoid following your half hour of Tai Chi by collapsing on your bed in your gym clothes and scrolling through social media for an hour while eating sugary snacks and enjoying a post-workout beer.
You should also avoid workout supplements if exercising before bed. While it's probably no surprise these energy-inducing drinks contain caffeine, you might be unaware of just how much of the stimulant you'll be consuming — a single supplement can contain the equivalent caffeine of three cups of coffee.
The science behind exercise and sleep is still developing — although this review emphasizes the importance of further research — so above all else, listen to your body.
And if you're experiencing long-term sleep deprivation or insomnia, we recommend speaking to a healthcare professional to develop a treatment plan.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Forget push-ups — according to a scientist, these are the only two upper-body exercises you'll ever need
When you buy through links on our articles, Future and its syndication partners may earn a commission. If you're looking to build your upper body, it turns out endless push-ups might not be the best way to go. According to Coach Pak Androulakis-Korakakis (who goes by Dr Pak), a Sports Scientist, researcher, and coach who specializes in the science of strength training, you only need two exercises to build your upper body. Read on to find out more. As a reminder, if you're new to exercise or you're returning to exercise following an injury or pregnancy, it's always a good idea to seek advice from a professional before taking on a new workout routine. What are the exercises? 'These two exercises are like the squat and deadlift for your upper body,' says Dr. Pak but unlike squats and deadlifts, you don't need tons of equipment — you can do both efficiently using just your body weight. The exercises in question? Chin-ups and dips. Here's how to do both exercises: Chin-ups To do a chin-up, you'll need a pull-up bar of some sort. These can be found in most gyms, but also in local parks for free. Dr. Pak says chin-ups are one of the simplest ways to get a bigger back and biceps — in fact, they target your chest, front delts, triceps, biceps and lats. He recommends going into a full stretch on the way down from your chin-up, keeping your muscles under tension for longer. Work until failure, and if you can do 15 reps easily, think about adding weight to the exercise, using a weighted belt or weighted vest. Here's how to do a chin-up with good form: Although chin-ups and pull-ups look similar, there's one major difference; the way you grip the bar. To perform a chin-up, you'll need to hold the bar with your palms facing you. Grab the bar with an underhand grip, with your hands shoulder-width apart. Keep your body in a straight line with your core engaged, and pull yourself up until your chin is above the bar. Hold this position for a moment, then lower back to the starting position. If you want to build up to an unaided chin-up, you can use resistance bands for support. Loop the band around the bar and place your knees into the band before starting the chin-up. As you develop strength, you can reduce the band's thickness to increase the intensity. Check out the best resistance bands for your workouts here. Dips The next exercise to try is dips, which work the chest, triceps, and front delts. You'll need a set of dip bars for this exercise, but again, these are super common and you'll find them in most gyms. Dr. Pak recommends going as low as you can comfortably go at the bottom of the movement, keeping your elbows close to your body, and your torso leaning slightly forward. Again, if these are too easy, you can always add weight with a best or vest, but for most people, you'll get a serious upper body workout using just your bodyweight. Here's how to do dips using a dip bar: Raise yourself onto two dip bars with straight arms Lower your body down to the ground, bending at the elbow. If you can keep going until your shoulders are lower than your elbows. Push into the bar, and lift your body up until you're back in your starting position, with your arms straight. What's the workout? Dr. Pak recommends doing these two exercises, plus a few sets of lateral raises, using a set of the best adjustable dumbbells, to work your entire upper body. Alternatively, use the two exercises above for an equipment-free workout, and do them as a superset. A superset in strength training means doing two exercises back-to-back with minimal or no rest in between. You'll often target opposing muscle groups, for example, your chest, followed by your back. Supersets are great if you're short on time. Here's Dr. Pak's upper body superset: Do a set of chin-ups to failure Rest for 10-20 seconds Do a set of dips to failure Rest for a couple of minutes Repeat four times, twice a week Follow Tom's Guide on Google News to get our up-to-date news, how-tos, and reviews in your feeds. Make sure to click the Follow button. More from Tom's Guide Forget pull-ups — you only need 5 moves and a pair of dumbbells to build upper body strength and improve your posture Ditch the gym! This 5-move strength workout sculpts upper body muscle with just a pair of dumbbells Build a stronger back and bigger biceps with this 20-minute dumbbell workout — no pull-ups needed Solve the daily Crossword


Forbes
40 minutes ago
- Forbes
Buy or Sell UNH Stock Ahead of Its Upcoming Earnings?
CHONGQING, CHINA - JULY 27: In this photo illustration, a smartphone displays the logo of ... More UnitedHealth Group Incorporated (NYSE: UNH), a leading American healthcare and insurance company, in front of a screen showing the company's latest stock market chart on July 27, 2025 in Chongqing, China. (Photo illustration by) UnitedHealth (NYSE:UNH) is set to release its earnings on Tuesday, July 29, 2025. Analyzing the past five years of data, UNH stock has exhibited a trend of positive one-day returns after earnings announcements in 53% of cases. The median one-day gain was 4.0%, with the highest single-day increase reaching 7.2%. While the actual results in comparison to consensus estimates will be vital, comprehending these historical patterns can offer an edge for event-driven traders. There are two primary strategies to leverage this information: Analysts' consensus estimates for the forthcoming quarter anticipate earnings of $4.94 per share on revenue of $111.6 billion. This stands in contrast to last year's quarter earnings of $6.80 per share on revenues of $98.86 billion. The expected contraction in profit margins, as indicated by the lower EPS estimate despite higher revenue, is mainly attributed to escalating medical costs. From a fundamental standpoint, UnitedHealth Group has a current market capitalization of roughly $267 billion. Over the past twelve months, the company generated $410 billion in revenue, reporting $33 billion in operating profits and a net income of $22 billion, showcasing robust operational profitability. That being said, if you're looking for potential upside with less volatility than individual stocks, the Trefis High Quality portfolio offers an alternative — having outperformed the S&P 500 and produced returns exceeding 91% since its inception. See earnings reaction history of all stocks UnitedHealth's Historical Odds Of Positive Post-Earnings Return Here are some insights on one-day (1D) post-earnings returns: Additional data for recorded 5-Day (5D) and 21-Day (21D) returns post earnings are detailed along with the statistics in the table below. UNH 1D, 5D, and 21D Post Earnings Return Correlation Between 1D, 5D, and 21D Historical Returns A relatively less risky approach (although not effective if the correlation is low) is to comprehend the correlation between short-term and medium-term returns following earnings, identify a pair that has the highest correlation, and execute the appropriate trade. For instance, if 1D and 5D reveal the highest correlation, a trader can position themselves "long" for the next 5 days if the 1D post-earnings return is positive. Below are some correlation statistics derived from the 5-year and 3-year (more recent) history. It is worth noting that the correlation 1D_5D refers to the correlation between 1D post-earnings returns and subsequent 5D returns. UNH Correlation Between 1D, 5D and 21D Historical Returns Discover more about Trefis RV strategy that has outperformed its all-cap stocks benchmark (combination of all 3, the S&P 500, S&P mid-cap, and Russell 2000), delivering strong returns for investors. Additionally, if you desire upside with a more stable experience than an individual stock like UnitedHealth, consider the High Quality portfolio, which has outperformed the S&P and achieved >91% returns since its launch.
Yahoo
an hour ago
- Yahoo
Hengrui Pharma and GSK link across key therapeutic areas
Hengrui Pharma has signed an agreement with GSK for the development of up to 12 innovative medicines across several therapeutic areas, including respiratory, immunology and inflammation, and oncology. The collaboration is poised to enhance Hengrui's globalisation strategy and provide GSK with significant growth opportunities beyond 2031. GSK will pay an upfront fee of $500m, which includes licensing for the phosphodiesterase (PDE)3/4 programme. The potential value of future success-based payments to Hengrui Pharma could be close to $12bn, assuming all programmes are optioned and milestones met. Hengrui Pharma is also set to receive tiered royalties on worldwide product net sales, with certain regional exclusions. A highlight of the agreement is the worldwide licence for HRS-9821, a PDE3/4 inhibitor in clinical development for chronic obstructive pulmonary disease (COPD). HRS-9821 aligns with GSK's goal to address a broad spectrum of COPD patients, including those with ongoing dyspnoea or those less likely to be prescribed inhaled corticosteroids or biologics. In early trials, this inhibitor showed positive anti-inflammatory and bronchodilation effects. Its potential for a dry-powder inhaler formulation could integrate well with GSK's existing inhaled portfolio. Hengrui Pharma executive vice-president and chief strategy officer Frank Jiang stated: 'GSK brings additional research and development expertise, a robust global clinical network and broad regulatory capabilities that will accelerate our PDE3/4 inhibitor as well as an array of other innovative therapy programmes to overseas markets, potentially delivering breakthrough treatments to patients globally." Beyond HRS-9821, the collaboration includes up to 11 additional programmes. Hengrui Pharma will spearhead the development up to Phase I trials, after which GSK may opt to develop further and commercialise the programmes globally, excluding mainland China, the Macau special administrative region (SAR), Hong Kong SAR and Taiwan. This scaled collaboration is designed to expedite the development of innovative medicines, leveraging GSK's expertise and global reach alongside Hengrui Pharma's discovery and clinical evaluation capabilities. The licensing of HRS-9821 is contingent upon customary regulatory clearances, including under the Hart-Scott-Rodino Act in the US. In March 2025, MSD entered an exclusive licence agreement with Hengrui Pharma for the investigational oral small-molecule lipoprotein(a) [Lp(a)] inhibitor, HRS-5346. "Hengrui Pharma and GSK link across key therapeutic areas" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.